Works matching IS 01615505 AND DT 2019 AND VI 60 AND IP 3

Results: 30

Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 377, doi. 10.2967/jnumed.118.215848

By:

Jingjing Zhang;
Kulkarni, Harshad R.;
Singh, Aviral;
Niepsch, Karin;
Müller, Dirk;
Baum, Richard P.

Publication type:

Article

Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 410, doi. 10.2967/jnumed.118.211953

By:

Gould, K. Lance;
Johnson, Nils P.;
Roby, Amanda E.;
Tung Nguyen;
Kirkeeide, Richard;
Haynie, Mary;
Dejian Lai;
Hongjian Zhu;
Patel, Monica B.;
Smalling, Richard;
Arain, Sal;
Balan, Prakash;
Nguyen, Tom;
Estrera, Anthony;
Sdringola, Stefano;
Madjid, Mohammad;
Nascimbene, Angelo;
Loyalka, Pranav;
Kar, Biswajit;
Gregoric, Igor

Publication type:

Article

Practical Methods for Estimating Metabolic Flux (Ki) to Assess Response to Therapy via Static PET Scans.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 320, doi. 10.2967/jnumed.118.220913

By:

Doot, Robert K.

Publication type:

Article

What 18F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 328, doi. 10.2967/jnumed.118.214148

By:

Turgeon, Guy-Anne;
Iravani, Amir;
Akhurst, Tim;
Beaulieu, Alexis;
Callahan, Jason W.;
Bressel, Mathias;
Cole, Aidan J.;
Everitt, Sarah J.;
Siva, Shankar;
Hicks, Rodney J.;
Ball, David L.;
Mac Manus, Michael P.

Publication type:

Article

Dixon-VIBE Deep Learning (DIVIDE) Pseudo-CT Synthesis for Pelvis PET/MR Attenuation Correction.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 429, doi. 10.2967/jnumed.118.209288

By:

Torrado-Carvajal, Angel;
Vera-Olmos, Javier;
Izquierdo-Garcia, David;
Catalano, Onofrio A.;
Morales, Manuel A.;
Margolin, Justin;
Soricelli, Andrea;
Salvatore, Marco;
Malpica, Norberto;
Catana, Ciprian

Publication type:

Article

Evaluation of 11C-Methionine PET and Anatomic MRI Associations in Diffuse Intrinsic Pontine Glioma.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 312, doi. 10.2967/jnumed.118.212514

By:

Tinkle, Christopher L.;
Duncan, Elizabeth C.;
Doubrovin, Mikhail;
Yuanyuan Han;
Yimei Li;
Hyun Kim;
Broniscer, Alberto;
Snyder, Scott E.;
Merchant, Thomas E.;
Shulkin, Barry L.

Publication type:

Article

Production of 15O for Medical Applications via the 16O(γ,n)15O Reaction.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 424, doi. 10.2967/jnumed.118.215681

By:

Queern, Stacy L.;
Cardman, Ryan;
Loveless, Christopher S.;
Shepherd, Matthew R.;
Lapi, Suzanne E.

Publication type:

Article

FROM THE LITERATURE.

Published in:: Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 10N
Publication type:: Article

News: SNMMI and SNMMI-TS 2019 Leadership Graduates.

Published in:: Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 8N
Publication type:: Article

Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 342, doi. 10.2967/jnumed.118.211912

By:

Schenke, Simone;
Seifert, Philipp;
Zimny, Michael;
Winkens, Thomas;
Binse, Ina;
Görges, Rainer

Publication type:

Article

Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog 177Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 393, doi. 10.2967/jnumed.118.207845

By:

Sauter, Alexander W.;
Mansi, Rosalba;
Hassiepen, Ulrich;
Muller, Lionel;
Panigada, Tania;
Wiehr, Stefan;
Wild, Anna-Maria;
Geistlich, Susanne;
Béhé, Martin;
Rottenburger, Christof;
Wild, Damian;
Fani, Melpomeni

Publication type:

Article

News: FDA Reviews NDA for 18F-FDOPA in Congenital Hyperinsulinism.

Published in:: Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 7N
Publication type:: Article

Thought Leaders to Gather at 2019 SNMMI Annual Meeting in Anaheim, CA.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 9N

By:

Pappas, Virginia

Publication type:

Article

Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 418, doi. 10.2967/jnumed.118.216556

By:

Linssen, Matthijs D.;
ter Weele, Eva J.;
Allersma, Derk P.;
Lub-de Hooge, Marjolijn N.;
van Dam, Gooitzen M.;
Jorritsma-Smit, Annelies;
Nagengast, Wouter B.

Publication type:

Article

An Imager’s Guide to Perineural Tumor Spread in Head and Neck Cancers: Radiologic Footprints on 18F-FDG PET, with CT and MRI Correlates.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 304, doi. 10.2967/jnumed.118.214312

By:

Lee, Hwan;
Lazor, Jillian W.;
Assadsangabi, Reza;
Shah, Jagruti

Publication type:

Article

Reply: Different Radionuclides in DOTA-EBTATE Effect Different Uptake in Somatostatin Receptor–Positive HEK293 Cells.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 436, doi. 10.2967/jnumed.118.223453

By:

Jacobson, Orit;
Xiaoyuan Chen

Publication type:

Article

Hexokinase-2 Expression in 11C-Methionine–Positive, 18F-FDG–Negative Multiple Myeloma.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 348, doi. 10.2967/jnumed.118.217539

By:

Kircher, Stefan;
Stolzenburg, Antje;
Kortüm, Klaus Martin;
Kircher, Malte;
Da Via, Matteo;
Samnick, Samuel;
Buck, Andreas K.;
Einsele, Hermann;
Rosenwald, Andreas;
Lapa, Constantin

Publication type:

Article

Different Radionuclides in DOTA-EB-TATE Effect Different Uptake in Somatostatin Receptor–Positive HEK293 Cells.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 436, doi. 10.2967/jnumed.118.220707

By:

Kotzerke, Jörg;
Runge, Roswitha;
Braune, Anja;
Wunderlich, Gerd

Publication type:

Article

18F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 335, doi. 10.2967/jnumed.118.213652

By:

Ito, Kimiteru;
Teng, Rebecca;
Schöder, Heiko;
Humm, John L.;
Ni, Ai;
Michaud, Laure;
Nakajima, Reiko;
Yamashita, Rikiya;
Wolchok, Jedd D.;
Weber, Wolfgang A.

Publication type:

Article

Performance of 68Ga-DOTA–Conjugated Somatostatin Receptor–Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 369, doi. 10.2967/jnumed.118.211706

By:

Sangwon Han;
Chong Hyun Suh;
Sungmin Woo;
Yeon Joo Kim;
Jong Jin Lee

Publication type:

Article

Discussions with Leaders: A Conversation between Simon Cherry and Johannes Czernin.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 295

By:

Cherry, Simon R.;
Czernin, Johannes

Publication type:

Article

Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 362, doi. 10.2967/jnumed.118.212233

By:

Giesel, Frederik L.;
Knorr, Karina;
Spohn, Fabian;
Will, Leon;
Maurer, Tobias;
Flechsig, Paul;
Neels, Oliver;
Schiller, Kilian;
Amaral, Horacio;
Weber, Wolfgang A.;
Haberkorn, Uwe;
Schwaiger, Markus;
Kratochwil, Clemens;
Choyke, Peter;
Kramer, Vasko;
Kopka, Klaus;
Eiber, Matthias

Publication type:

Article

Erratum.

Published in:: Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 438
Publication type:: Article

Reply: Radiation Dose Does Matter: Mechanistic Insights into DNA Damage and Repair Support the Linear No-Threshold Model of Low-Dose Radiation Health Risks.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 437, doi. 10.2967/jnumed.118.223461

By:

Duncan, James R.;
Lieber, Michael R.;
Adachi, Noritaka;
Wahl, Richard L.

Publication type:

Article

Quantitative Coronary Flow Capacity for Risk Stratification and Clinical Decision Making: Is It Ready for Prime Time?

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 407, doi. 10.2967/jnumed.118.219717

By:

Di Carli, Marcelo F.;
Hachamovitch, Rory

Publication type:

Article

68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 386, doi. 10.2967/jnumed.118.215913

By:

Giesel, Frederik L.;
Kratochwil, Clemens;
Lindner, Thomas;
Marschalek, Manfred M.;
Loktev, Anastasia;
Lehnert, Wencke;
Debus, Jürgen;
Jäger, Dirk;
Flechsig, Paul;
Altmann, Annette;
Mier, Walter;
Haberkorn, Uwe

Publication type:

Article

Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 353, doi. 10.2967/jnumed.118.216069

By:

Burley, Thomas A.;
Da Pieve, Chiara;
Martins, Carlos D.;
Ciobota, Daniela M.;
Allott, Louis;
Oyen, Wim J. G.;
Harrington, Kevin J.;
Smith, Graham;
Kramer-Marek, Gabriela

Publication type:

Article

Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 400, doi. 10.2967/jnumed.118.214403

By:

Banerjee, Sangeeta Ray;
Kumar, Vivek;
Lisok, Ala;
Plyku, Donika;
Nováková, Zora;
Brummet, Mary;
Wharram, Bryan;
Barinka, Cyril;
Hobbs, Robert;
Pomper, Martin G.

Publication type:

Article

Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of 18F-Fluoride Metabolic Flux Than with Measurement of 18F-Fluoride PET/CT SUV?

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 322, doi. 10.2967/jnumed.118.208710

By:

Azad, Gurdip K.;
Siddique, Musib;
Taylor, Benjamin;
Green, Adrian;
O’Doherty, Jim;
Gariani, Joanna;
Blake, Glen M.;
Mansi, Janine;
Goh, Vicky;
Cook, Gary J. R.

Publication type:

Article

First Human Imaging Studies with the EXPLORER Total-Body PET Scanner.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 299, doi. 10.2967/jnumed.119.226498

By:

Badawi, Ramsey D.;
Hongcheng Shi;
Pengcheng Hu;
Shuguang Chen;
Tianyi Xu;
Price, Patricia M.;
Yu Ding;
Spencer, Benjamin A.;
Nardo, Lorenzo;
Weiping Liu;
Jun Bao;
Jones, Terry;
Hongdi Li;
Cherry, Simon R.

Publication type:

Article

Works matching IS 01615505 AND DT 2019 AND VI 60 AND IP 3

Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.

Regional, Artery-Specific Thresholds of Quantitative Myocardial Perfusion by PET Associated with Reduced Myocardial Infarction and Death After Revascularization in Stable Coronary Artery Disease.

Practical Methods for Estimating Metabolic Flux (Ki) to Assess Response to Therapy via Static PET Scans.

What <sup>18</sup>F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non–Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?

Dixon-VIBE Deep Learning (DIVIDE) Pseudo-CT Synthesis for Pelvis PET/MR Attenuation Correction.

Evaluation of <sup>11</sup>C-Methionine PET and Anatomic MRI Associations in Diffuse Intrinsic Pontine Glioma.

Production of <sup> 15</sup>O for Medical Applications via the <sup>16</sup>O(γ,n)<sup>15</sup>O Reaction.

FROM THE LITERATURE.

News: SNMMI and SNMMI-TS 2019 Leadership Graduates.

Risk Stratification of Thyroid Nodules Using the Thyroid Imaging Reporting and Data System (TIRADS): The Omission of Thyroid Scintigraphy Increases the Rate of Falsely Suspected Lesions.

Targeting of the Cholecystokinin-2 Receptor with the Minigastrin Analog <sup>177</sup>Lu-DOTA-PP-F11N: Does the Use of Protease Inhibitors Further Improve In Vivo Distribution?

News: FDA Reviews NDA for <sup>18</sup>F-FDOPA in Congenital Hyperinsulinism.

Thought Leaders to Gather at 2019 SNMMI Annual Meeting in Anaheim, CA.

Roadmap for the Development and Clinical Translation of Optical Tracers Cetuximab-800CW and Trastuzumab-800CW.

An Imager’s Guide to Perineural Tumor Spread in Head and Neck Cancers: Radiologic Footprints on 18F-FDG PET, with CT and MRI Correlates.

Reply: Different Radionuclides in DOTA-EBTATE Effect Different Uptake in Somatostatin Receptor–Positive HEK293 Cells.

Hexokinase-2 Expression in <sup> 11</sup>C-Methionine–Positive, <sup>18</sup>F-FDG–Negative Multiple Myeloma.

Different Radionuclides in DOTA-EB-TATE Effect Different Uptake in Somatostatin Receptor–Positive HEK293 Cells.

<sup>18</sup>F-FDG PET/CT for Monitoring of Ipilimumab Therapy in Patients with Metastatic Melanoma.

Performance of <sup> 68</sup>Ga-DOTA–Conjugated Somatostatin Receptor–Targeting Peptide PET in Detection of Pheochromocytoma and Paraganglioma: A Systematic Review and Metaanalysis.

Discussions with Leaders: A Conversation between Simon Cherry and Johannes Czernin.

Detection Efficacy of <sup>18</sup>F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.

Erratum.

Reply: Radiation Dose Does Matter: Mechanistic Insights into DNA Damage and Repair Support the Linear No-Threshold Model of Low-Dose Radiation Health Risks.

Quantitative Coronary Flow Capacity for Risk Stratification and Clinical Decision Making: Is It Ready for Prime Time?

<sup>68</sup>Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.

Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models.

Evaluation of <sup>111</sup>In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen.

Is Response Assessment of Breast Cancer Bone Metastases Better with Measurement of <sup>18</sup>F-Fluoride Metabolic Flux Than with Measurement of <sup>18</sup>F-Fluoride PET/CT SUV?

First Human Imaging Studies with the EXPLORER Total-Body PET Scanner.